After crackdown on spurious medicines, India’s drug regulator collating data of pharma plants

The companies have also been asked to share information on international approvals obtained from the European Union, US Food and Drug Administration, Japan's Pharmaceuticals and Medical Devices Agency, Brazilian Health Regulatory Agency (Anvisa), among other regulatory bodies abroad.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news